论文部分内容阅读
目的探讨妈富隆治疗青春期功能失调性子宫出血的临床效果。方法收集2012年12月—2014年12月收治的106例青春期功能失调性子宫出血患者的临床资料,根据入院顺序随机将106例患者分为观察组(例数=53)和对照组(例数=53),对照组采用常规乙烯雌酚联合安宫黄体酮治疗,观察组采用妈富隆治疗,连续治疗3周,比较两组患者治疗总有效率及出血控制时间、完全止血时间、子宫内膜厚度等指标。结果经过3周连续治疗,观察组患者治疗总有效率为92.4%,对照组为83.0%,二者相比,差异存在统计学意义(P<0.05);观察组患者出血控制时间为(20.5±5.1)h,完全止血时间为(43.3±11.9)h,子宫内膜厚度为(4.6±1.0)mm,各指标均优于对照组,差异均有统计学意义(P<0.05)。结论妈富隆治疗青春期功能失调性子宫出血能有效控制患者出血症状,疗效确切,值得临床推广应用。
Objective To investigate the clinical effect of Marvelon in the treatment of adolescent dysfunctional uterine bleeding. Methods The clinical data of 106 patients with adolescent dysfunctional uterine bleeding who were admitted from December 2012 to December 2014 were collected. 106 patients were randomly divided into observation group (n = 53) and control group (n = = 53). The control group was treated with conventional diethylstilbestrol and medroxyprogesterone acetate. The observation group was treated with Marvelon for 3 weeks. The total effective rate, bleeding control time, complete hemostasis time, endometrium Thickness and other indicators. Results After 3 weeks of continuous treatment, the total effective rate of the observation group was 92.4% and that of the control group was 83.0%, the difference was statistically significant (P <0.05); the bleeding control time of the observation group was (20.5 ± 5.1) h, the complete hemostasis time was (43.3 ± 11.9) h, and the thickness of endometrium was (4.6 ± 1.0) mm. There were significant differences between the two groups (P <0.05). Conclusion Marvelon treatment of adolescent dysfunctional uterine bleeding can effectively control the patient’s bleeding symptoms, the curative effect is exact, worthy of clinical promotion and application.